Technology

Qiagen

$54.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.60 (+1.12%) Today
+$0.47 (+0.87%) As of 1:55 PM UTC after-hours

Why Robinhood?

You can buy or sell Qiagen and other stocks, options, and ETFs commission-free!

About QGEN

Qiagen NV, also called Qiagen, is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands. The listed name for QGEN is Qiagen NV.

CEO
Thierry Bernard
Employees
5,096
Headquarters
Venlo, Limburg
Founded
1996
Market Cap
12.45B
Price-Earnings Ratio
66.18
Dividend Yield
—
Average Volume
743.01K
High Today
$54.69
Low Today
$53.86
Open Price
$54.06
Volume
536.63K
52 Week High
$55.27
52 Week Low
$32.97

Collections

QGEN Earnings

$0.00
$0.19
$0.39
$0.58
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 4

You May Also Like

COW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure